Skip to main content
. 2019 Jan 10;9(5):902–922. doi: 10.1016/j.apsb.2019.01.004

Figure 4.

Fig. 4

Schematic illustration of rational design of octaarginine-based nanoparticles and their hypoglycemic effect in rats78. Adapted from Niu et al.168 with permission © 2018 Elsevier Ltd.